These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37142331)

  • 1. Lacrimal gland activity in lacrimal drainage obstruction: exploring the potential cross-talk between the tear secretion and outflow.
    Singh S; Srivastav S; Bothra N; Paulsen F; Ali MJ
    Br J Ophthalmol; 2024 Mar; 108(4):621-624. PubMed ID: 37142331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacrimal Gland Volume Changes in Unilateral Primary Acquired Nasolacrimal Obstruction.
    Yazici A; Bulbul E; Yazici H; Sari E; Tiskaoglu N; Yanik B; Ermis S
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4425-9. PubMed ID: 26193918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced tear break-up time in the fellow eye of patients with unilateral primary acquired nasolacrimal duct obstruction.
    Tıskaoğlu NS; Yazıcı A
    Int Ophthalmol; 2023 Mar; 43(3):965-971. PubMed ID: 36053478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear instability in the fellow eye of unilateral nasolacrimal obstruction and resolution with dacryocystorhinostomy.
    Tıskaoğlu NS; Yazıcı A
    Orbit; 2023 Aug; 42(4):404-410. PubMed ID: 36069079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the meibomian glands in postmenopausal women with primary acquired nasolacrimal duct obstruction: a prospective study.
    Jin H; Zhang H
    BMC Ophthalmol; 2023 Feb; 23(1):48. PubMed ID: 36726065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meibomian Gland Dysfunction in Primary Acquired Nasolacrimal Duct Obstruction.
    Yoon S; Lee H; Baek S
    J Craniofac Surg; 2023 Jun; 34(4):e395-e398. PubMed ID: 37157128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry eye and decreased tear film stability in primary acquired nasolacrimal duct obstruction patients.
    Yu X; Wang K; Hu Y; Meng Z; Li J; Liu Y; Xiao L; Chen M; Li S; Shen Y; Chen R; Liang X
    Int Ophthalmol; 2024 Jun; 44(1):277. PubMed ID: 38916702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective controlled study of vapor pressure tear osmolality and tear meniscus height in nasolacrimal duct obstruction.
    Stahl U; Francis IC; Stapleton F
    Am J Ophthalmol; 2006 Jun; 141(6):1051-6. PubMed ID: 16765672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of Tear Cytokine Expressions in Primary Acquired Nasolacrimal Duct Obstruction - Potential Insights into the Etiopathogenesis.
    Ali MJ; Patnaik S; Kelkar N; Ali MH; Kaur I
    Curr Eye Res; 2020 Apr; 45(4):435-439. PubMed ID: 31490706
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of pyridostigmine (Mestinon) in the relief of patients with epiphora.
    Yazicioglu T; Oklar M; İnan R
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103240. PubMed ID: 36592783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacrimal drainage function after cheese wiring of lacrimal passage intubation.
    Koh S; Ochi S; Inoue Y
    Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1087-1093. PubMed ID: 32006089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Videoreflective dacryomeniscometry in normal adults and in patients with functional or primary acquired nasolacrimal duct obstruction.
    Francis IC; Chan DG; Papalkar D; Papas EB; Stapleton F
    Am J Ophthalmol; 2005 Mar; 139(3):493-7. PubMed ID: 15767059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrolytes and electrophoretic studies of tear proteins in tears of patients with nasolacrimal duct obstruction.
    Lew H; Yun YS; Lee SY
    Ophthalmologica; 2005; 219(3):142-6. PubMed ID: 15947499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction.
    Girard B; Piaton JM; Keller P; Abadie C; Nguyen TH
    J Fr Ophtalmol; 2017 Oct; 40(8):661-665. PubMed ID: 28847443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct visualization of aqueous tear secretion from lacrimal gland.
    Kim EC; Doh SH; Chung SY; Yoon SY; Kim MS; Chung SK; Shin MC; Hwang HS
    Acta Ophthalmol; 2017 Jun; 95(4):e314-e322. PubMed ID: 27879057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of pH, electrolytes and electrophoretic studies of tear proteins in tears of patients with dacryoliths: a novel concept for dacryoliths.
    Lew H; Lee SY; Yun YS
    Ophthalmologica; 2004; 218(2):130-5. PubMed ID: 15004503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of mucins in human lacrimal sac and nasolacrimal duct.
    Paulsen FP; Corfield AP; Hinz M; Hoffmann W; Schaudig U; Thale AB; Berry M
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):1807-13. PubMed ID: 12714609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher incidence of meibomian gland dysfunction in postmenopausal women with primary acquired nasolacrimal duct obstruction.
    Wang G; Jin H; Sheng Y; Ji F; Liu Y; Han L; Wang X; Chen X; Ding H; Liu J; Fu Q
    Int Ophthalmol; 2024 Feb; 44(1):70. PubMed ID: 38349418
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.